Shane Miersch
Waterloo, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Molecular characterization of a synthetic neutralizing antibody targeting p67 of Theileria parva.
Journal: Protein science : a publication of the Protein Society
Published: June 05, 2024
Structural Survey of Antigen Recognition by Synthetic Human Antibodies.
Journal: Cold Spring Harbor protocols
Published: April 09, 2024
Cell-based passive immunization for protection against SARS-CoV-2 infection.
Journal: Stem cell research & therapy
Published: February 20, 2023
Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site.
Journal: PLoS pathogens
Published: September 13, 2022
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants.
Journal: ACS chemical biology
Published: June 22, 2022
Monoclonal antibodies binding data for SARS-CoV-2 proteins.
Journal: Data in brief
Published: May 05, 2022
Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein.
Journal: Communications biology
Published: April 07, 2022
Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins.
Journal: Journal of molecular biology
Published: February 18, 2022
Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids.
Journal: Cells
Published: January 24, 2022
Synthetic antibodies block receptor binding and current-inhibiting effects of α-cobratoxin from Naja kaouthia.
Journal: Protein science : a publication of the Protein Society
Published: January 15, 2022
Last Updated: 09/26/2026